![]() doi:10.3322/caac.There are various mutations the EGFR protein can have. Cancer treatment and survivorship statistics, 2019. Miller KD, Nogueira L, Mariotto AB, et al. Relapsed small-cell lung cancer: platinum re-challenge or not. Advances in immunotherapy for treatment of lung cancer. ![]() Targeted therapy for non-small cell lung cancer: current standards and the promise of the future. Stereotactic body radiotherapy for oligometastatic disease in non-small cell lung cancer. Optimising treatment for post-operative lung cancer recurrence. Therapeutic radiation and the potential risk of second malignancies. Kamran SC, Berrington de Gonzalez A, Ng A, Haas-Kogan D, Viswanathan AN. Radiation induced secondary malignancies: a review article. ![]() Paraneoplastic syndromes in lung cancer and their management. Liver metastases.Īnwar A, Jafri F, Ashraf S, Jafri MAS, Fanucchi M. Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies. Lung cancer warning signs.ĭ’Antonio C, Passaro A, Gori B, et al. Relapsed small cell lung cancer: treatment options and latest developments. Prognosis of recurrent non-small cell lung cancer following complete resection. Recurrence after surgery in patients with NSCLC. Local recurrence following lung cancer surgery: incidence, risk factors, and outcomes. Recurrent cancer: when cancer comes back.įedor D, Johnson WR, Singhal S. Prognosis of recurrence after complete resection in early-stage non-small cell lung cancer. What is cancer recurrence?Ĭhoi PJ, Jeong SS, Yoon SS.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |